Ahmed Alenezi

Ahmed Alenezi

Auto-generated profile, based on publicly available information

Ahmed Alenezi

Department of Radiological Sciences, King Saud University, Riyadh, Saudi Arabia

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2014 in Annals of the ICRP
Verified
Journal Article
Open access
AAA. Alenezi
A. Alenezi
KSkhaled M soliman
khaled M soliman
Over the past decade, the number of positron emission tomography/computed tomography (PET/CT) imaging procedures has increased substantially. This imaging technique provides accurate functional and anatomical information, particularly for oncological applications. Separately, both PET and CT are considered as high-dose imaging modalities. With the increased use of PET/CT, one could expect an increase in radiation doses to staff and patients. As such, major efforts have been made to reduce radiation dose in PET/CT facilities. Variations in working techniques have made it difficult to compare published results. This study aimed to review the literature on proposed methods to reduce patient and staff dose in clinical PET/CT imaging. A brief overview of some published information on staff and patient doses will be analysed and presented. Recent trends regarding radiation protection in PET/CT imaging will be discussed, and practical recommendations for reducing radiation doses to staff and patients will be discussed and summarised. Generally, the CT dose component is often higher in magnitude than the dose from PET alone; as such, focusing on CT dose reduction will decrease the overall patient dose in PET/CT imaging studies. The following factors should be considered in order to reduce the patient's dose from CT alone: proper justification for ordering contrast-enhanced CT; use of automatic exposure control features; use of adaptive statistical iterative reconstruction algorithms; and optimisation of scan parameters, especially scan length. The PET dose component can be reduced by administration of lower activity to the patient, optimisation of the workflow, and appropriate use of protective devices and engineered systems. At the international level, there is wide variation in work practices among institutions. The current observed trends are such that the annual dose limits for radiation workers in PET/CT imaging are unlikely to be exceeded.

28 December 2018 in International Journal of Radiology
Verified
Journal Article
Open access
PDF file
KSkhaled M soliman
khaled M soliman
AAAhmed Alenezi
Ahmed Alenezi
TATurki Alruwaili
Turki Alruwaili
SASalman Altimyat
Salman Altimyat
AAAbdullah Alrushoud
Abdullah Alrushoud
MAMohammed Alkhorayef
Mohammed Alkhorayef
Five Years Review of Occupational Dosimetry Program at A Tertiary Care Hospital and Comparison With UNSCEAR 2008 Report

30 September 2013 in Radiation Protection Dosimetry
Verified
Journal Article
Closed access
PDF file
KSkhaled M soliman
khaled M soliman
AAA. Alenezi
A. Alenezi
The aim of this study was to test the feasibility of using Gafchromic XR-QA2 films in the measurements of patient entrance surface dose (ESD) during the micturating cystourethrogram (MCUG) examination in paediatric patients. Radiochromic films were used to map the entrance dose and to identify the location of peak surface dose (PSD). Direct in vivo measurements of entrance dose were conducted by placing a radiochromic film between the patient and the examination table. The measured ESD values for the commonly performed MCUG fluoroscopic examinations at the authors' institution was in the range of 1.2–7.8 mGy and the PSD in the range of 1.2–8.5 mGy per MCUG procedure for patients with age ranging from 1 to 12 y old. Gafchromic films (XR-QA2) were found to be an efficient and practical dosimetry method that can be easily used to measure clinical patient entrance doses during fluoroscopically guided procedures and potentially in other diagnostic investigations.

21 June 2022 in Radiation Physics and Chemistry
Verified
Journal Article
Closed access
KAKhalid Alzimami
Khalid Alzimami
LJLayal Jambi
Layal Jambi
EMEssam Mattar
Essam Mattar
AAAhmed Alenezi
Ahmed Alenezi
AAAbdulrahman Alfuraih
Abdulrahman Alfuraih
DBDAVID BRADLEY
DAVID BRADLEY

1 February 2015 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
KSkhaled M soliman
khaled M soliman
AAAhmed Alenezi
Ahmed Alenezi
The aim of the study was to measure the actual dose at 1 m from the patients per unit activity with the aim of providing a more accurate prediction of the dose levels around radioiodine patients in the hospital, as well as to compare our results with the literature. In this work the demonstration of a patient body tissue attenuation factor is verified by comparing the dose rates measured from the patients with those measured from the unshielded radioiodine capsules immediately after administration of the radioactivity. The normalized dose rate per unit activity is therefore proposed as an operational quantity that can be used to predict exposure rates to staff and patients’ relatives. The average dose rate measured from our patient per unit activity was 38.4±11.8 μSv/h/GBq. The calculated attenuation correction factor based on our measurements was 0.55±0.17. The calculated dose rate from a radioiodine therapy patient should normally include a factor accounting for patient body tissue attenuation and scatter. The attenuation factor is currently neglected and not applied in operational radiation protection. Realistic estimation of radiation dose levels from radioiodine therapy patients when properly performed will reduce the operational cost and optimize institutional radiation protection practice. It is recommended to include patient attenuation factors in risk assessment exercises – in particular, when accurate estimates of total effective doses to exposed individuals are required when direct measurements are not possible. The information provided about patient attenuation might benefit radiation protection specialists and regulators.

1 May 2020 in Nuclear Medicine Communications
Verified
Journal Article
Closed access
KSkhaled M soliman
khaled M soliman
HAHasna Albander
Hasna Albander
AAAhmed Alenezi
Ahmed Alenezi
Purpose Radioiodine ablation treatment (RAT) is administered to papillary thyroid carcinoma patients post thyroidectomy. Multivariable logistic regression analysis can be applied to predict treatment failure. In this study, we propose a logistic regression model (LRM) to estimate the probability of repeating the treatment more than one time. Materials and methods A retrospective review of the last 5 years of RAT data revealed that 30 patients had received the RAT more than one time. Various factors including age, sex, pretreatment serum thyroglobulin (Tg), thyroid-stimulating hormone (TSH) and administered activity were analyzed to predict RAT failure and therefore the necessity to repeat the treatment by administering additional doses of radioiodine. Results The administered activity, the patient age, the presence of distant lymph nodes on the whole-body radioiodine scan (WBS) and the level of Tg before the treatment were found to be the predictive variables. The following LRM is proposed: Y = 7.8295 − 0.0012 [Activity in (MBq) − 0.0541 (Age) − 34.3 (Lymph Nodes) − 0.0042 (Tg)]. The prediction accuracy of the LRM was assessed using receiver operating characteristic (ROC) curve by calculating the area under the curve (AUC). We found the AUC = 0.8972. Conclusion Patients who are older in age, who receive higher administered radioiodine activity, have higher serum thyroglobulin levels and have lymph node uptake reported in their post-ablation WBS are more likely to have unsuccessful treatment outcome and will repeat the treatment. This LRM could help in adjusting RAT options in order to reduce the repeat rate.